INVH vs SBRA
Invitation Homes vs Sabra Health Care REIT — AI-powered side-by-side comparison
INVH
Invitation Homes
57
Buy
VS
SBRA
Sabra Health Care REIT
50
Watch
| Metric | INVH | SBRA |
|---|
| AI Score |
57
|
50
|
| Price |
$30.21
|
$20.83
|
| P/E Ratio |
27.72×
|
78.86×
|
| ROE |
6.2%
|
5.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
44.4%
|
72.6%
|
| Debt / Equity |
0.94×
|
0.96×
|
| Dividend Yield |
3.9%
|
5.8%
|
| RSI (14) |
52.5
|
60.0
|
| Beta |
0.836
|
0.643
|
| Expected Upside |
+3.7%
|
+1.1%
|
AI Committee View
Current Innellis committee reasoning for INVH versus SBRA.
INVH leads by 7 points.
INVH scores 57/100 (Buy) versus SBRA at 50/100 (Watch).
INVH Committee View
67% agreement
6 analysts
Positive signals support the current rating — 5 consecutive earnings beats -- consistent execution. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Dividend yield of 3.1% pays you to wait — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 27.0 is moderate-to-rich — Value
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
- Current ratio of 0.42 is tight -- limited short-term liquidity cushion — Risk
SBRA Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case. Growth Analyst remains cautious — 4 consecutive earnings misses -- execution concerns. This disagreement is itself the signal — the setup is not clean in either direction.
Bear Case
- 4 consecutive earnings misses -- execution concerns — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical